R3 Vascular Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease (NCT06071429) | R3 Vascular Inc. | 2025-04-11 |
| Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia (NCT06075940) | R3 Vascular Inc. | 2024-03-04 |
| Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease (NCT04912323) | R3 Vascular Inc. | 2021-08-17 |
Track R3 Vascular Inc. automatically
Every clearance here is in the API, with alerts when new ones post.